The Extent of Axillary Surgery Is Associated With Breast Cancer-specific Survival in T1–2 Breast Cancer Patients With 1 or 2 Positive Lymph Nodes: A SEER-Population Study

por Li, Shunrong, Liu, Fengtao, Chen, Kai, Rao, Nanyan, Xie, Yufen, Su, Fengxi, Zhu, Liling
Publicado 2016

Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: study protocol for a randomized pilot trial

por Wu, Wei, Deng, Heran, Rao, Nanyan, You, Na, Yang, Yaping, Cao, Minghui, Liu, Jieqiong
Publicado 2017

Risk factors of catheter-related thrombosis in early-stage breast cancer patients: a single-center retrospective study

por Tan, Luyuan, Sun, Ya, Zhu, Liling, Lei, Xin, Liang, Dongya, Rao, Nanyan, Su, Fengxi, Chen, Kai, Li, Shunrong
Publicado 2019

The Effect of Low and High Vacuum Drainage on the Postoperative Drainage of Breast Cancer: Insights from a Prospective, Non-Inferiority, Randomized Clinical Trial

por Lin, Wanyi, Yang, Yaping, Zhong, Wenjing, Lin, Qun, Rao, Nanyan, Liang, Gehao, Ling, Yun, Liu, Zihao, Luo, Qing, Tian, Zhenluan, Gong, Chang
Publicado 2020

Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: a randomized pilot trial

por Wu, Wei, Chen, Jiewen, Deng, Heran, Jin, Liang, He, Zhanghai, Rao, Nanyan, Nie, Yan, Yao, Yandan, Yang, Yaping, Su, Fengxi, Liu, Jieqiong
Publicado 2021

A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrosp...

por Gu, Ran, Jia, Weijuan, Zeng, Yunjie, Rao, Nanyan, Hu, Yue, Li, Shunrong, Wu, Jiannan, Jin, Liang, Chen, Lijuan, Long, Meijun, Chen, Kai, Chen, Lili, Xiao, Qiaozhen, Wu, Mei, Song, Erwei, Su, Fengxi
Publicado 2012

HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after initial lumpectomy

por Jia, Haixia, Jia, Weijuan, Yang, Yaping, Li, Shunrong, Feng, Huiyi, Liu, Jieqiong, Rao, Nanyan, Jin, Liang, Wu, Jiannan, Gu, Ru, Zhu, Liling, Chen, Kai, Deng, Heran, Zeng, Yunjie, Liu, Qiang, Song, Erwei, Su, Fengxi
Publicado 2014

Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial

por Li, Junjie, Yu, Keda, Pang, Da, Wang, Changqin, Jiang, Jun, Yang, Suisheng, Liu, Yunjiang, Fu, Peifen, Sheng, Yuan, Zhang, Guojun, Cao, Yali, He, Qi, Cui, Shude, Wang, Xijing, Ren, Guosheng, Li, Xinzheng, Yu, Shiyou, Liu, Pengxi, Qu, Xiang, Tang, Jinhai, Wang, Ouchen, Fan, Zhimin, Jiang, Guoqin, Zhang, Jin, Wang, Jiandong, Zhang, Hongwei, Wang, Shui, Zhang, Jianguo, Jin, Feng, Rao, Nanyan, Ma, Binlin, He, Pingqing, Xu, Binghe, Zhuang, Zhigang, Wang, Jianfeng, Sun, Qiang, Guo, Xiaofeng, Mo, Miao, Shao, Zhimin
Publicado 2020